Billionaire Profile
Chung Yong-ji
Global Rank
#272

Image: 玄史生 | CC0 | via Wikimedia Commons

Chung Yong-ji

CEO, Biotech
SOUTH KOREA
Real-Time Net Worth
$11.26B
Estimated based on Biotech stock value as of March 6, 2026
+4.88% (24h)
Age
55
Source
Biotech
Industry
Healthcare
Citizenship
SOUTH KOREA

Biography

Chung Yong-ji is a prominent South Korean businessman and the founder and CEO of Caregen, a biotechnology company specializing in peptide-based cosmetics and healthcare products. Born in Seoul, South Korea, in 1970, Chung has built a successful career in the biotech industry. His educational background includes a Ph.D. in Molecular Biology from Cornell University. Chung founded Caregen in 2001, and the company went public in 2015. With Caregen's products sold in over 130 countries, Chung has become a self-made billionaire. His wealth comes from his 64% stake in Caregen.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Chung Yong-ji was born in Seoul, South Korea, on February 25, 1970. He pursued higher education, earning a Bachelor of Science in Genetic Engineering from Sungkyunkwan University, a Master's degree in Biology from the University of Texas at San Antonio, and a Ph.D. in Molecular Biology (Animal Science) from Cornell University. Following his academic pursuits, he conducted postdoctoral research at Northwestern University Feinberg School of Medicine.

Rise to Success

Chung founded Caregen in August 2001. Caregen specializes in peptide-based cosmetics and healthcare products. The company's initial public offering (IPO) occurred in 2015 on the KOSDAQ, raising approximately $160 million. As of late 2023, Chung holds a significant 64% stake in the company. Caregen's success is built on its innovative peptide technology, with a focus on products like anti-wrinkle treatments and Dr. CYJ Hair Filler for hair regrowth.

Key Business Strategies

Caregen's business strategy revolves around peptide-based research and development. The company has developed over 360 patented peptides. The company has expanded globally, with its products available in over 130 countries, with major markets in the Middle East, North Africa, Europe, and the Asia Pacific regions. Chung's vision includes expanding into the bio field, developing treatments for conditions like COVID-19, macular degeneration, and diabetes.

Philanthropy

While specific amounts are not readily available in the search results, it's important to note that Chung Yong-ji is involved in the business sector, and his company is developing products that aim to improve health and well-being.

Career Milestones

2001

Founded Caregen

Founded the biotechnology company Caregen, specializing in peptide-based products.

2015

Caregen IPO

Caregen listed on the KOSDAQ, raising $160 million.